VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Bovine respiratory syncytial virus glycoprotein G mutant vaccine
Vaccine Information
  • Vaccine Name: Bovine respiratory syncytial virus glycoprotein G mutant vaccine
  • Target Pathogen: Bovine Respiratory Syncytial Virus
  • Target Disease: Respiratory Disease
  • Vaccine Ontology ID: VO_0002951
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Cow
  • glycoprotein G gene engineering:
    • Type: Gene mutation
    • Description: This glycoprotein G mutant is from Bovine respiratory syncytial virus (Schmidt et al., 2002).
    • Detailed Gene Information: Click Here.
  • Immunization Route: intranasal immunization
Host Response

Cattle Response

  • Persistence: A glycoprotein G mutant is attenuated in calves (Schmidt et al., 2002).
  • Efficacy: A glycoprotein G mutant induces significant protection in calves from challenge with wild type BRSV (Schmidt et al., 2002).
References
Schmidt et al., 2002: Schmidt U, Beyer J, Polster U, Gershwin LJ, Buchholz UJ. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV. Journal of virology. 2002; 76(23); 12355-12359. [PubMed: 12414977].